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Abstract A simple strategy using selective codon optimization 
was devised to express mouse c-Fos protein in high levels in 
E. coli. Ten arginine codons located in the basic region were 
optimized to achieve high levels of protein expression. The c-Fos 
protein was purified to near homogeneity and was demonstrated 
to be biologically active by assaying its several biological 
activities. 
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1. Introduction 
Activator protein (AP-1) was originally identified as a tran-
scriptional factor binding to a «i-element of the human met-
allothionein Ha (hMT lia) promoter [1]. The binding site for 
AP-1 was very quickly recognized as the TPA (12-O-tetrade-
canoylphorbol 13-acetate) response element (TRE) of several 
cellular and viral genes including human MT Ha, collagenase, 
stromelysin, c-jun, interleukin 2 (IL2), SV40 and polyoma [1]. 
In addition to TPA, AP-1 activity has been shown to be 
regulated by many other stimuli including growth factors, 
cytokines and DNA damaging agents [1]. 
Subsequent studies revealed that AP-1 is a dimeric complex 
of the gene products of two different gene families: jun family 
and fos family. The jun family includes c-jun, JunB and JunD 
and fos family includes c-fos, fosB, fral and fra2. While differ-
ent Jun proteins can homo- and heterodimerize within the 
family and bind TRE specifically, different Fos proteins can-
not. However, Fos proteins can dimerize with Jun proteins 
and bind TRE specifically regular size[l]. 
AP-1 activity can be altered by regulating the level of differ-
ent Jun and Fos proteins or alternatively by modifying differ-
ent Jun and Fos proteins in response to extracellular signals. 
The easy availability of recombinant c-Jun proteins has been 
instrumental in determining its role in regulation of genes 
involved in many different biological processes and in eluci-
dating the detailed signal transduction pathway regulating its 
activity in response to external stimuli. 
It is well documented that synonymous codons are not used 
randomly in various organisms and these nonrandom usage of 
synonymous codons has been shown to correlate with the rela-
tive quantities of various tRNAs [2]. It has been suggested that 
the codon usage may affect protein expression in the cell [2]. This 
concept has been tested in a few studies [see [3] for an example]. 
These studies showed that insertion of rare codons into highly 
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expressed cDNAs can negatively affect the expression level of 
the mutated cDNAs, and furthermore, the effects were much 
stronger when the inserted rare codons were located closer to 
the initiation codon. In fact, some groups have achieved high 
levels of expression of different genes by using total synthetic 
cDNAs based on the optimal codon usage concept [4-6]. 
Although rat c-Fos protein has been expressed in and pu-
rified from E. coli by using a totally synthetic c-fos cDNA 
with optimal E. coli codons [4], mouse and human c-Fos 
proteins have not been expressed in E. coli. The strategy 
used for expressing rat c-Fos in E. coli is theoretically appli-
cable to the expression of other mammalian genes in E. coli, 
but the strategy has not often been adopted for practical 
reasons. 
Here I describe the expression and purification of mouse 
c-Fos in E. coli. The strategy is simpler than the previous 
one used for expressing rat c-Fos proteins in E. coli and there-
fore should be more easily adaptable to the expression of 
other mammalian genes in E. coli. 
2. Materials and methods 
2.1. Construction of pTH6-cfos 
pTD2 [7] was modified to generate pTH6, which contains a trans-
lation initiation codon followed by 6 histidine codons and then a 
multiple cloning region with Nco\, Nhe\, EcoRl, Hindlll and BamHl 
in the stated order. The detailed description of pTH6 construction will 
be available upon request. 
To construct pTH6-cfos, a fragment between a Sail in the 3' un-
translated region of mouse c-fos cDNA and a Sail in the multiple 
cloning region of pGEM4-fos was deleted by digesting with Sail and 
relegating. Then the £coRI-//mdIII fragment containing c-fos cDNA 
was subcloned into Bluescript KS(+)II and single-stranded DNA was 
obtained. The single-stranded DNA was used for mutagenesis to cre-
ate a Ncol site at the translation initiation site. Mutagenesis was 
performed on the single-stranded template using the appropriate oli-
godeoxynucleotides (whose description is available upon request) and 
the Amersham site-directed mutagenesis kit as recommended by the 
manufacturer. The mutations were initially identified by creation of 
restriction sites. Final confirmation was by direct sequencing. The 
c-fos cDNA fragment containing the entire coding region was sub-
cloned into pTH6 to generate pTH6-cfos. 
2.2. Expression and purification of recombinant cFos proteins 
To express c-Fos, pTH6-cfos plasmids containing wild-type and 
different codon-optimizing coding DNAs were transformed into Es-
cherichia coli BL21 (DE3) pLysS. The cells were grown to an OD of 
0.6 in a 37°C shaking incubator, induced by the addition of 1 mM 
isopropyl-1-thio-ß-D-galactopyranoside (IPTG). Samples were taken 
at different times after induction and analyzed by SDS-PAGE. The 
plasmid expressing the highest level of c-Fos was used for expression 
and purification of c-Fos. The Fos proteins were purified from inclu-
sion bodies and renatured as described [8]. Protein concentrations 
were determined by the Bradford assay (Bio-Rad). 
2.3. Immunoblotting 
The proteins were resolved by electrophoresis in a 10% SDS-PAGE 
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basic leucine 
region zipper 
AGA. 
CGC 
140 141 142 143 144 145 146 155 156 157 158 159 
. CGG AGA ATC CGA AGG GAA CGG. . . CGG AAT CGG AGG AGG 
CGC CGT ATC CGT CGC GAA CGT CGT AAT CGT CGT CGC 
Fig. 1. A diagram of c-Fos and the codon optimization scheme. 
The basic region and the leucine zipper region of c-Fos is shown. 
The ten wild-type arginine codons located between amino acid 119 
and 159 of the basic region and the optimized codons are shown. 
The mutant containing the optimized arginine codons from amino 
acid 140 to amino acid 146 is designated as Ml and the mutant 
containing all ten optimized codons M2. 
and electro-transferred to a nitrocellulose. The nitrocellulose was 
blocked in PBS buffer (80 mM Na2HP04, 20 mM NaH2P04, 100 
mM NaCl, pH 7.5) with 0.1% Tween 20 supplemented with 5% nonfat 
milk at 4°C. Fos proteins were detected by incubation of the nitro-
cellulose with Fos antibody 14C1 (1:1000) at 4°C for 1 h [9], followed 
by rinsing and detection with an Amersham ECL kit. The secondary 
antibody was also diluted 1:1000. 
2.4. Mobility-shift assay 
Mobility-shift assays contained the indicated amounts of the differ-
ent cJun/JunB chimera CB4 [4] and Fos proteins, 1 ng of 32P-labeled 
collagenase phorbol 12-myristate 13-acetate response element (TRE) 
probe, 5 μg poly(dl-dC), 12 mM HEPES-KOH (pH 8.0), 50 mM KC1, 
6 mM MgCl2, 1 mM EDTA, 10% (vol/vol) glycerol, 5 mM dithio-
threitol, and 80 μg of bovine serum albumin in a total volume of 20 μΐ. 
After a 20-min incubation at room temperature, reaction mixtures 
were loaded on 5% native polyacrylamide gels (acrylamide/bisacryl-
amide, 40:1). Electrophoresis was done in 0.4 X Tris/borate/EDTA 
buffer (TBE; 1XTBE is 90 mM Tris/90 mM boric acid/2 mM 
EDTA, pH 8.3) at room temperature. The gel was dried and exposed 
to an X-ray film. 
2.5. Kinase reaction and two-dimensional phosphopeptide mapping 
The recombinant c-Fos proteins were incubated at 30°C for 30 min 
with the relevant kinases in kinase buffer (20 mM HEPES, pH 7.3, 
10 mM MgCl2, 20 mM ß-glycerophosphate, 20 mM ^-nitrophenyl-
phosphate, 0.1 mM NaV04, 2 mM DTT) containing 10 μΜ [γ-
32Ρ] 
ATP in 20 μΐ. Reactions were terminated by addition of 6.5 μί 
4 X SDS-PAGE sample buffer and boiling. Purified ERK1/2 is a mix-
ture of both enzymes (gift from M. Cobb) and PKA is from Promega. 
The reaction mixtures were loaded on a 10% SDS-PAGE gel. The gel 
was dried and exposed to an X-ray film (Amersham). For two-dimen-
sional phosphopeptide mapping, the gel-resolved proteins were elec-
trophoretically transferred to a nitrocellulose (Schleicher and Schuell). 
The nitrocellulose was exposed to an X-ray film. The phosphorylated 
c-Fos bands were excised and digested by trypsin (Worthington). The 
samples were further processed to obtain the two-dimensional peptide 
mapping as described [10,11]. 
Fig. 2. Analysis of protein expression of different c-Fos expression vectors. (A) SDS-PAGE analysis of various bacterial samples. Lanes: 1^·, 
samples of pTH6-cFos at 0, 1, 3, 5 h after IPTG inductions; 5-8, samples of pTH6-cFos Ml at 0, 1, 3, 5 h after IPTG induction; 9-12, sam-
ples of pTH6-cFos M2 at 0, 1, 3, 5 h after IPTG induction; 13, soluble fraction of the 5 h sample of pTH6-cFos M2; 14, inclusion body frac-
tion of the 5 h sample of pTH6-cFos M2; 15, purified c-Fos. Lane M, molecular weight markers. The size of each marker is indicated at the 
right and labeled in kDa. (B) Immunoblotting analysis. Lanes: 1-3, 3 h after IPTG induction samples of PTH6-cFos, Ml and M2, respec-
tively; 4, purified cFos. The cFos position is indicated. 
T. DenglFEBS Letters 409 (1997) 269-272 
Fig. 3. Stimulations of CB4 DNA binding activity by c-Fos. The in-
dicated amount of protein (ng/reaction) was mixed with a 32P-la-
beled Col-TRE probe. The migration positions of the different pro-
tein-DNA complexes are indicated. The free probe is at the bottom. 
3. Results 
To express c-Fos in bacteria, wild-type c-fos cDNA was 
inserted into pTH6 and pET-8c, respectively. A schematic 
illustration of c-Fos is shown in Fig. 1. As shown in Fig. 
2A, c-Fos proteins were not detectably expressed from the 
expression vector pTH6-cfos. The same results were also ob-
tained with pET-8c-cfos (data not shown). 
One possible explanation for the failure to express mouse 
c-Fos at high levels in E. coli is the prevalence of codons 
infrequently utilized in E. coli in the c-fos sequence [12]. Care-
ful examination of mouse c-fos sequence revealed that the 
most significant difference of codon usage between the mouse 
c-fos and the genes highly expressed in E. coli is the codons 
for arginine. Therefore, attempts were made to optimize co-
don usage for arginine of mouse c-fos. It should be noted that 
codon optimization does not alter the encoded amino acid 
sequence. Initially, five arginine codons between amino acid 
140 and 146 were optimized (Fig. 1). However, this optimiza-
tion was still not enough to express c-Fos at high levels in 
E. coli (Fig. 2A). Additional five arginine codons, one for Arg 
119 and the other four for arginine codons between amino 
acid 155 and 159, were optimized (Fig. 1). Significantly, 
high levels of c-Fos were expressed in E. coli (Fig. 2A). The 
highest level of expression was obtained 3 h after IPTG in-
duction and was determined to be about 20% of total bacte-
rial proteins based on density scanning quantitation of the 
Coomassie Blue-stained gel shown in Fig. 2A. c-Fos proteins 
were present in both the soluble fraction and the inclusion 
body. c-Fos proteins were purified from the inclusion body. 
The purity of the mouse c-Fos protein was estimated to be at 
least 95% based on density scanning quantitation of the Coo-
massie Blue-stained gel (Fig. 2A). 
As shown in Fig. 2A, some protein bands comigrated with 
the overexpressed protein band, which has the same apparent 
mobility as the purified cFos. To determine whether those 
Fig. 4. Phosphorylation of c-Fos by ERK1/2 and PKA in vitro. (A) 
Purified c-Fos was mixed with ERK1/2 or PKA as indicated in ki-
nase buffer containing [γ-32Ρ]ΑΤΡ. Phosphorylated proteins were 
separated by SDS-PAGE and visualized by autoradiography. Bands 
corresponding to c-Fos are indicated. (B) Two-dimensional tryptic 
map of c-Fos phosphorylated in vitro by ERK1/2. (C) Two-dimen-
sional tryptic map of c-Fos phosphorylated in vitro by PKA. 2, 3 
and 4 refer to the principal phosphopeptides that migrate like phos-
phopeptides derived from the C-terminal region of c-Fos as de-
scribed by Tratner et al. [14]. 
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faint bands which comigrated with purified cFos represent low 
level expression of cFos, a Western blot analysis was per-
formed using a cFos N-terminal specific monoclonal antibody 
14C1 [9]. As shown in Fig. 2B, those faint bands did not con-
tain cFos proteins and the overexpressed band reacted with 
the antibody strongly. Furthermore, the result demonstrated 
that the simple optimization of ten rare arginine codons can 
improve cFos expression in bacteria from the undetectable 
level to about 20% of total bacterial proteins. 
To test whether the purified c-Fos was biologically active, 
gel-retardation was used to examine the interaction of c-Fos 
with a TRE probe and its interaction with CB4, a cJun/Jun B 
chimera containing the N-terminal region of cJun and the C-
terminal DNA-binding region of JunB [8]. As expected, CB4 
did not bind TRE efficiently while cFos did not at all (Fig. 3). 
However, cFos stimulated CB4-TRE interaction significantly 
(Fig. 3), suggesting that the bacterially-expressed and purified 
c-Fos was able to interact with CB4 to form a CB4-cFos 
complex to bind TRE efficiently, a property expected of bio-
logically active c-Fos proteins. Interestingly, the CB4-cFos-
TRE complex seems to migrate slightly faster than the CB4-
TRE complex. A likely explanation is that the CB4-cFos-TRE 
is a more compact complex than the CB4.CB4-TRE is and 
thus migrates faster. 
c-Fos was previously shown to contain ERK (extracellular 
signal regulated kinase) and PKA (protein kinase A) phos-
phorylation sites [13,14]. To further test whether the purified 
c-Fos was biologically active, the purified c-Fos was incubated 
with ERK1/2 and PKA, respectively, in the presence of γ-32Ρ-
ATP. The purified c-Fos was efficiently phosphorylated by 
both ERK1/2 and PKA (Fig. 4A). To ascertain that ERK1/ 
2 and PKA phosphorylated the purified c-Fos at the appro-
priate sites, two-dimensional (2D) tryptic phosphopeptide 
mapping was performed with the c-Fos proteins phosphoryl-
ated by ERK 1/2 and PKA. The 2D map for c-Fos phos-
phorylated by ERK 1/2 contained two spots, spot 2 and spot 
4 (Fig. 4B). The 2D map for c-Fos phosphorylated by PKA 
contained one predominant spot, spot 3 (Fig. 4C). The results 
are consistent with the earlier results that ERK1/2 is able to 
phosphorylate c-Fos at Ser 374 to give rise to the spot 2 and 
spot 4 [10] and PKA is able to phosphorylate c-Fos at Ser 362 
to give rise to the spot 3 [14]. 
4. Discussion 
In this report, I describe the high-level expression of mouse 
c-Fos in E. coli and purification of biologically active c-Fos 
from the over-producing strain. It has been known for some 
time that there are significant differences of codon usage be-
tween different species [2]. This is especially true between the 
prokaryotic and eukaryotic species [12]. This difference has 
been used to explain the difficulty encountered when trying 
to express certain mammalian proteins in E. coli. 
Earlier studies had focused either on achieving high levels 
of expression by using synthetic cDNAs with optimal codons 
or on studying the effect of rare codons by inserting them into 
otherwise highly expressed cDNAs in bacteria. Here, I offer a 
clear example that codon usage indeed affects expression of 
mammalian genes in E. coli dramatically, from undetectable 
to 20% of total bacterial proteins. Surprisingly, although there 
is a fairly large number of unfavorable codons in c-fos se-
quence, optimization of ten arginine codons clustered around 
the DNA binding domain of c-Fos is all that is necessary for 
high-level expression of mouse c-Fos in E. coli. This observa-
tion clearly has implication for expressing other members of 
fos family in E. coli and probably for expressing many other 
mammalian genes in E. coli as well. The easy availability of 
c-Fos and other mammalian proteins from E. coli will clearly 
have some advantages over other systems in certain applica-
tions and will therefore help researchers study the proteins of 
their interests. 
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